Suitability of Marine- and Porcine-Derived Collagen Type I Hydrogels for Bioprinting and Tissue Engineering Scaffolds

Mar Drugs. 2022 May 30;20(6):366. doi: 10.3390/md20060366.

Abstract

Collagens from a wide array of animals have been explored for use in tissue engineering in an effort to replicate the native extracellular environment of the body. Marine-derived biomaterials offer promise over their conventional mammalian counterparts due to lower risk of disease transfer as well as being compatible with more religious and ethical groups within society. Here, collagen type I derived from a marine source (Macruronus novaezelandiae, Blue Grenadier) is compared with the more established porcine collagen type I and its potential in tissue engineering examined. Both collagens were methacrylated, to allow for UV crosslinking during extrusion 3D printing. The materials were shown to be highly cytocompatible with L929 fibroblasts. The mechanical properties of the marine-derived collagen were generally lower than those of the porcine-derived collagen; however, the Young's modulus for both collagens was shown to be tunable over a wide range. The marine-derived collagen was seen to be a potential biomaterial in tissue engineering; however, this may be limited due to its lower thermal stability at which point it degrades to gelatin.

Keywords: 3D printing; bioink; collagen; hydrogel; methacrylation; source; stability.

MeSH terms

  • Animals
  • Biocompatible Materials
  • Bioprinting*
  • Collagen
  • Collagen Type I
  • Gelatin
  • Hydrogels
  • Mammals
  • Swine
  • Tissue Engineering
  • Tissue Scaffolds

Substances

  • Biocompatible Materials
  • Collagen Type I
  • Hydrogels
  • Gelatin
  • Collagen

Grants and funding

Financial support was received from the Global Challenges Joint Ph.D. Program between the University of Wollongong and CSIRO. Additional support was received from the Australian National Fabrication Facility (ANFF)–Materials Node, and Funding from the Australian Research Council Centre of Excellence Scheme (Project Number CE 140100012) is gratefully acknowledged. Gordon Wallace 397 acknowledges the support of the ARC through an ARC Laureate Fellowship (FL110100196).